IgNS was recently featured on SamaCare’s The Road to Care podcast, where leaders Luba Sobolevsky, PharmD, IgCP®, and Amy Clarke, DNP, RN, IgCN®, shared insights on Ig therapy standards, education, and advocacy, as well as the history, challenges, and future of immunoglobulin (Ig) therapy.
In this wide-ranging discussion, Sobolevsky and Clarke spoke about:
- The origins of IgNS and the need to establish clinical standards of practice in Ig therapy
- How education, certification, and collaboration are elevating clinical care
- The importance of patient advocacy and shared decision-making in long-term Ig therapy
- Opportunities and challenges facing the field as new therapies and biologics emerge
One of the most powerful takeaways was a reminder of IgNS’s commitment to patients and providers. As Sobolevsky noted during the podcast:
“We have a very cohesive, strong industry in the Ig therapy space. And I know we all want the same thing—for our patients on this life-saving therapy to have the best experience at every infusion, the best outcomes, and the best quality of life they can. At IgNS, we’re committed to continuing this work long term, with the support and backing of our industry partners.”
Listen to the full episode on your preferred platform: